These findings, together with the previous demonstration of VE-cadherin tyrosine phosphorylation in tumors, suggest that such modifications of VE-cadherin might occur in response to tumor microenvironment in human brain tumors. The gene discussed is CDH5; the disease is brain neoplasm.